These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
825 related articles for article (PubMed ID: 25727991)
1. Silencing Angiopoietin-Like Protein 4 (ANGPTL4) Protects Against Lipopolysaccharide-Induced Acute Lung Injury Via Regulating SIRT1 /NF-kB Pathway. Guo L; Li S; Zhao Y; Qian P; Ji F; Qian L; Wu X; Qian G J Cell Physiol; 2015 Oct; 230(10):2390-402. PubMed ID: 25727991 [TBL] [Abstract][Full Text] [Related]
2. Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via NF-κB Signaling Pathway in vivo and in vitro. Niu X; Liu F; Li W; Zhi W; Zhang H; Wang X; He Z Inflammation; 2017 Aug; 40(4):1111-1122. PubMed ID: 28365871 [TBL] [Abstract][Full Text] [Related]
3. Isotetrandrine protects against lipopolysaccharide-induced acute lung injury by suppression of mitogen-activated protein kinase and nuclear factor-kappa B. Liang XM; Guo GF; Huang XH; Duan WL; Zeng ZL J Surg Res; 2014 Apr; 187(2):596-604. PubMed ID: 24331940 [TBL] [Abstract][Full Text] [Related]
4. Silencing of Paralemmin-3 Protects Mice from lipopolysaccharide-induced acute lung injury. Li S; Guo L; Zhao Y; Qian P; Lv X; Qian L; Wang Q; Qian G; Yao W; Wu X Peptides; 2016 Feb; 76():65-72. PubMed ID: 26772416 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of PKR ameliorates lipopolysaccharide-induced acute lung injury by suppressing NF-κB pathway in mice. Li Y; Xiao J; Tan Y; Wang J; Zhang Y; Deng X; Luo Y Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):165-172. PubMed ID: 28511573 [TBL] [Abstract][Full Text] [Related]
6. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway. Feng G; Sun B; Li TZ Int Immunopharmacol; 2015 Jun; 26(2):392-400. PubMed ID: 25887269 [TBL] [Abstract][Full Text] [Related]
7. Regulation on the expression of Clara cell secretory protein in the lungs of the rats with acute lung injury by growth hormone. Min J; Luo FQ; Zhao WL Chin Med J (Engl); 2012 Aug; 125(15):2728-33. PubMed ID: 22931982 [TBL] [Abstract][Full Text] [Related]
8. Knockdown of angiopoietin-like 4 suppresses sepsis-induced acute lung injury by blocking the NF-κB pathway activation and hindering macrophage M1 polarization and pyroptosis. Sun B; Bai L; Li Q; Sun Y; Li M; Wang J; Shi X; Zhao M Toxicol In Vitro; 2024 Feb; 94():105709. PubMed ID: 37820748 [TBL] [Abstract][Full Text] [Related]
9. Protective effect of resveratrol against acute lung injury induced by lipopolysaccharide via inhibiting the myd88-dependent Toll-like receptor 4 signaling pathway. Zhang Z; Chen N; Liu JB; Wu JB; Zhang J; Zhang Y; Jiang X Mol Med Rep; 2014 Jul; 10(1):101-6. PubMed ID: 24818579 [TBL] [Abstract][Full Text] [Related]
10. Taraxacum officinale protects against lipopolysaccharide-induced acute lung injury in mice. Liu L; Xiong H; Ping J; Ju Y; Zhang X J Ethnopharmacol; 2010 Jul; 130(2):392-7. PubMed ID: 20510343 [TBL] [Abstract][Full Text] [Related]
11. Ulinastatin post-treatment attenuates lipopolysaccharide-induced acute lung injury in rats and human alveolar epithelial cells. Luo Y; Che W; Zhao M Int J Mol Med; 2017 Feb; 39(2):297-306. PubMed ID: 27959396 [TBL] [Abstract][Full Text] [Related]
12. Naringin attenuates acute lung injury in LPS-treated mice by inhibiting NF-κB pathway. Liu Y; Wu H; Nie YC; Chen JL; Su WW; Li PB Int Immunopharmacol; 2011 Oct; 11(10):1606-12. PubMed ID: 21640201 [TBL] [Abstract][Full Text] [Related]
13. The effect of magnolol on the Toll-like receptor 4/nuclear factor κB signaling pathway in lipopolysaccharide-induced acute lung injury in mice. Yunhe F; Bo L; Xiaosheng F; Fengyang L; Dejie L; Zhicheng L; Depeng L; Yongguo C; Xichen Z; Naisheng Z; Zhengtao Y Eur J Pharmacol; 2012 Aug; 689(1-3):255-61. PubMed ID: 22683864 [TBL] [Abstract][Full Text] [Related]
14. Protective effect of taraxasterol on acute lung injury induced by lipopolysaccharide in mice. San Z; Fu Y; Li W; Zhou E; Li Y; Song X; Wang T; Tian Y; Wei Z; Yao M; Cao Y; Zhang N Int Immunopharmacol; 2014 Apr; 19(2):342-50. PubMed ID: 24548765 [TBL] [Abstract][Full Text] [Related]
15. Ulinastatin inhibits the inflammation of LPS-induced acute lung injury in mice via regulation of AMPK/NF-κB pathway. Li W; Qiu X; Jiang H; Zhi Y; Fu J; Liu J Int Immunopharmacol; 2015 Dec; 29(2):560-567. PubMed ID: 26481965 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of miR-221 alleviates LPS-induced acute lung injury via inactivation of SOCS1/NF-κB signaling pathway. Wang T; Jiang L; Wei X; Dong Z; Liu B; Zhao J; Wang L; Xie P; Wang Y; Zhou S Cell Cycle; 2019 Aug; 18(16):1893-1907. PubMed ID: 31208297 [TBL] [Abstract][Full Text] [Related]
17. Ulinastatin Protects Against LPS-Induced Acute Lung Injury By Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators. Cao C; Yin C; Shou S; Wang J; Yu L; Li X; Chai Y Shock; 2018 Nov; 50(5):595-605. PubMed ID: 29324628 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-92a antagonism attenuates lipopolysaccharide (LPS)-induced pulmonary inflammation and injury in mice through suppressing the PTEN/AKT/NF-κB signaling pathway. Fu L; Zhu P; Qi S; Li C; Zhao K Biomed Pharmacother; 2018 Nov; 107():703-711. PubMed ID: 30138892 [TBL] [Abstract][Full Text] [Related]
19. Knockdown of versican V1 induces a severe inflammatory response in LPS-induced acute lung injury via the TLR2-NF-κB signaling pathway in C57BL/6J mice. Xu L; Xue T; Zhang J; Qu J Mol Med Rep; 2016 Jun; 13(6):5005-12. PubMed ID: 27109786 [TBL] [Abstract][Full Text] [Related]
20. Suppression of NLRP3 and NF-κB signaling pathways by α-Cyperone via activating SIRT1 contributes to attenuation of LPS-induced acute lung injury in mice. Liu X; Jin X; Yu D; Liu G Int Immunopharmacol; 2019 Nov; 76():105886. PubMed ID: 31520990 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]